Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.

G. Norman, S. Rice, E. Spackman, L. Stirk, A. Danso-Appiah, D. Suh, S. Palmer, A. Eastwood

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)33-42
Number of pages10
JournalHealth Technology Assessment
Volume15 Suppl 1
DOIs
StatePublished - May 2011

ASJC Scopus Subject Areas

  • Health Policy

Cite this